Illinois Medicine

addicts in mindfulness or "intentional awareness" through meditation and other methods. A past president of the Illinois Society of Addiction Medicine, he is a recent recipient of the society's Lifetime Achievement Award. Angres is a diplomat of the American Board of Psychiatry and Neurology with added qualifications in addiction psychiatry, and he is certified by the American Society of Addiction Medicine. Bristow Has Practiced '81 What He Preached When Michael R. Bristow '66, MD '70, PhD '71, told incoming M1s at their White Coat Ceremony in August that "society has honored you with this oppor- tunity, but it's up to you to justify this faith bestowed," he was telling them to not only "do as I say"—but also do as he has done throughout his career. Bristow, a professor of medicine and cardiology at University of Colorado-Denver, might have been modest about his area of specialty when he told the new College of Medicine students that "95 percent of what you eventually do will be easy and literally require nothing more than your brain running in first gear; then there is the 5 percent where you don't initially know what is going on and what you end up doing can determine life and death." Bristow has led a dual career as an academic researcher and phar- macologic entrepreneur. As chief of cardiology and co-director of the University of Colorado Cardiovascular Institute, Bristow has undertaken pioneering work in elucidating the molecular mechanisms responsible for heart failure and determining how to use beta-blockers to treat it. "Those have turned into drug development opportunities," he says. "The discovery occurs at the university, and then as soon as something is ready to go commercial," he begins to develop it for market on the private side. Bristow has founded a total of four companies, two of which he's sold and two of which he's still involved with day to day. He co-founded Miragen Therapeutics Inc., which develops new cardiovascular drugs by using the biologic properties of microRNA; and he continues as president and CEO of ARCA biopharma, a Broomfield, Colo.-based company that he founded in 2002. A developer of genetically targeted therapies for heart failure and other cardiovascular diseases, ARCA has produced a cardiovascular drug called Gencaro that's currently under FDA review and that would treat people with certain genetic variants of adrenergic receptors. "What you do counts: Your effort, your tenacity, your compassion, your creativity and your character will all summate into who you are as a medical professional," Bristow told the students donning their white coats. "Your professors and, most of all, your patients will certainly re- member the name—make sure that remembrance is framed in gratitude and respect." — Ed Finkel David B. Seifer, MD '81, received an Inventor of the Year Award from the New Jersey Inventors Hall of Fame in October and a Thomas Alva Edison Patent Award from the Research & Development Council of New Jersey in November. These awards are given to scientists and inventors to recognize important sci- entific breakthroughs and innovations that originated in New Jersey and which resulted in a U.S. and/or world- wide patent. Seifer's patents describe the use of a blood test measuring Mullerian Inhibiting Substance, also known as Anti-Mullerian Hormone, for assessing the status of a woman's egg supply. This test is widely used in reproductive medicine and research in more than 50 countries worldwide to predict ovarian hyperstimulation and menopause, and to assess female fertility and the egg supply of women before and after chemotherapy for the treatment of cancer. Seifer's co- inventor is David MacLaughlin, PhD, of Massachusetts General Hospital and Harvard Medical School. Seifer is a clinical professor of obstetrics, gy- necology and reproductive sciences at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson and NYU medical schools. '84 40 | WINTER 2012 Frederick E. Miller, MD, Res '84, was named to OCD Chicago's Scientific Advisory Board, which provides guidance to OCD Chicago on medical and treatment matters related to obsessive compulsive disorder and serves as an informal speakers' bureau. Miller is the chair of the department of psychiatry and behavioral sciences at NorthShore University HealthSystem, a position he has held since 1999. He also serves as medical director of the Phoenix Program, which provides medication management, short-term therapy and case management for individuals with severe and persistent mental illness. Miller completed his doctoral training in pharmacological and physiological sciences at the Uni- versity of Chicago, while also earning an MD with honors, and he served as chief resident while at the University of Illinois. Miller is the producer of five films on teen mental health, and the creator of There's No Such Thing As Crazy, a film and Internet-based anti- stigma venture. Honors for his films have included the Telly Award and the SAMHSA Voice Award from the federal Substance Abuse and Mental Health Services Administration. '85 David R. Fett, MD, Res '85, has published a new sus- pense novel, White Sleeper, with veteran author Stephen Langford, through Synergy Books. The novel is about the threat of a domestic bioterrorist attack. Fett is a board-certified oph- thalmologist and fellowship-trained ophthalmic plastic surgeon, special- izing in reconstructive and cosmetic surgery around the eye. He practices in Los Angeles and is an assistant clinical professor at the UCLA School of Medicine. Fett earned his MD from Dartmouth Medical School, com- pleted his ophthalmology residency at UCLA and the Jules Stein Eye Institute and fellowship training in ophthalmic plastic and reconstruc- tive surgery at University of Illinois. He also holds a master's degree in toxicology from MIT. While in medical school, under the auspices of MIT and the National Cancer Institute, Fett used his toxicology training and Spanish fluency to help uncover the epidemiologic source and subse- quently find a solution for a Colom- bian indigenous community plagued by stomach cancer. He is at work on his next book, White Lies. '86 Paul A. Jones, MD '86, Res '89, chief of cardiovascular servic- es at Mercy Hospital PHOTO: DIANE SMUTNY

• Cover